Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Int J Clin Pharmacol Ther ; 47(3): 165-8, 2009 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-19281725

RESUMEN

OBJECTIVE: To report a case of an uncommon and up to date unpublished peracute and overwhelming muscle pain following administration of ciprofloxacin. CASE SUMMARY: A 58-year-old male developed fulminating musculoskeletal pain associated with third-time exposure to ciprofloxacin administered for treatment of chronic otitis media. Symptoms resolved slowly after intense combined analgetic therapy and cessation of ciprofloxacin therapy. 24 h after ciprofloxacin discontinuation the symptoms had completely disappeared and no more analgetic treatment was needed. Laboratory values, especially muscle enzymes, did not reveal any pathological pattern. The patient's past medical history highlighted reproducible side effects with both systemic and local administration of ciprofloxacin including milder symptoms of the musculoskeletal system. DISCUSSION: Common side effects of fluoroquinolones include gastrointestinal, central nervous and allergic reactions, but also more uncommon reactions such as tendonitis and rhabdomyolysis. In our case, there had been no signs of rhabdomyolysis. Besides an elevated IgE level no clinical signs of a true anaphylactic reaction associated with release of mast cell mediators had been observed. A pharmacokinetic interaction between ciprofloxacin and the patient's comedication carbamazepine is unlikely to be the responsible mechanism, since fluoroquinolones inhibit cytochrome P450 isoenzyme CYP1A2 but not CYP3A4 which metabolizes carbamazepine. CONCLUSION: To our knowledge, this is the first report describing fulminating musculoskeletal pain following administration of ciprofloxacin without any signs of rhabdomyolysis. Physicians should notice that there is a variety of adverse reactions of this usually well-tolerated agent and they should be aware of unusual complaints of their patients who receive fluoroquinolone treatment.


Asunto(s)
Antibacterianos/efectos adversos , Ciprofloxacina/efectos adversos , Enfermedades Musculares/inducido químicamente , Dolor/inducido químicamente , Enfermedad Aguda , Antibacterianos/uso terapéutico , Enfermedad Crónica , Ciprofloxacina/uso terapéutico , Urgencias Médicas , Humanos , Inyecciones Intravenosas , Masculino , Persona de Mediana Edad , Enfermedades Musculares/tratamiento farmacológico , Otitis Media/tratamiento farmacológico , Dolor/tratamiento farmacológico
2.
Med Klin (Munich) ; 90 Suppl 1: 32-5, 1995 Jan 15.
Artículo en Alemán | MEDLINE | ID: mdl-7715582

RESUMEN

Numerous studies support the theory that oxygen free radicals (OR) are involved in the development of tissue damage in all forms of experimental acute pancreatitis. OR are generated in an early phase of the disease before tissue damage is detectable by histology. The pathomechanism that leads to this oxidative stress is not fully understood. The efficacy of scavenger treatment was clearly proven in most models of experimental acute pancreatitis. In first clinical trials applying antioxidant treatment with selenium show favorable results in reducing the lipidperoxidation and improving the antioxidant status. However these preliminary results but must be supported in a larger series of patients to allow proper evaluation of patient outcome.


Asunto(s)
Pancreatitis/tratamiento farmacológico , Especies Reactivas de Oxígeno/metabolismo , Selenio/administración & dosificación , Radicales Libres , Glutatión/sangre , Humanos , Infusiones Intravenosas , Peroxidación de Lípido/efectos de los fármacos , Malondialdehído/sangre , Necrosis , Estrés Oxidativo , Pancreatitis/mortalidad , Pancreatitis/fisiopatología , Selenio/deficiencia , Tasa de Supervivencia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA